3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Papillary renal cell carcinoma, sporadic
1
Osteoradionecrosis
1
Mouth Neoplasms
1
Hereditary leiomyomatosis and renal cell cancer
1
Glioma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Bevacizumab
12
atezolizumab
9
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Nivolumab
6
lenvatinib
4
durvalumab
4
tremelimumab
3
cabozantinib
3
Sorafenib
3
Ipilimumab
3
ulixertinib
2
tislelizumab
2
relatlimab
2
donafenib
2
camrelizumab
2
apatinib
2
X-Rays
2
Surgical Procedures, Operative
2
Oxaliplatin
2
Leucovorin
2
Immunotherapy
2
Immune Checkpoint Inhibitors
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Contrast Media
×
30 days
×
Clear all
No trials found.